Back to Rare Disease

NCT00958841

NCT00958841
Terminated Phase 2 🇦🇺 Australian site

Who may be able to join

Who might be able to join this trial:

  • You must be at least 18 years old (male or female)
  • You must have a rare type of tumour that comes from hormone-producing tissues, such as tumours of the pancreas, pituitary gland, Nelson syndrome, or a tumour that produces a hormone called ACTH from an unusual location in the body (confirm with trial site)
  • You must have already tried standard treatments that did not work, or there must be no standard treatment available for your condition
  • You must be willing and able to sign a consent form agreeing to take part

Who may not be able to join:

  • You cannot join if you currently have an active gallbladder disease or condition
  • You cannot join if you are currently receiving or planning to receive any cancer treatment or a therapy called interferon
  • You cannot join if your diabetes is not well controlled
  • You cannot join if you are pregnant, breastfeeding, or are able to become pregnant and are not using a medically approved form of contraception

Important: There may be additional eligibility requirements not listed here. Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Trial details

Status
Terminated
Phase
Phase 2
Sponsor
Novartis Pharmaceuticals
Registry
clinicaltrials_gov
Start date
1 September 2009
Est. completion
1 June 2015

Where this trial is recruiting

🇦🇷 Argentina 🇦🇺 Australia 🇧🇷 Brazil 🇨🇦 Canada 🇫🇷 France 🇩🇪 Germany 🇮🇹 Italy 🇲🇽 Mexico 🇷🇺 Russia 🇪🇸 Spain 🇹🇭 Thailand 🇺🇸 United States

2 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

Percentage of Responders at Month 6 - Pooled Pancreatic NETs (PNETs)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov